These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28668835)

  • 21. Stress-induced Norepinephrine Downregulates CCL2 in Macrophages to Suppress Tumor Growth in a Model of Malignant Melanoma.
    Steinberger KJ; Bailey MT; Gross AC; Sumner LA; Voorhees JL; Crouser N; Curry JM; Wang Y; DeVries AC; Marsh CB; Glaser R; Yang EV; Eubank TD
    Cancer Prev Res (Phila); 2020 Sep; 13(9):747-760. PubMed ID: 32518084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity.
    Chen ML; Yan BS; Lu WC; Chen MH; Yu SL; Yang PC; Cheng AL
    Int J Cancer; 2014 Jan; 134(2):319-31. PubMed ID: 23818246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor and immunomodulatory effects of salvigenin on tumor bearing mice.
    Noori S; Hassan ZM; Yaghmaei B; Dolatkhah M
    Cell Immunol; 2013; 286(1-2):16-21. PubMed ID: 24270218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of orally administered maitake α-glucan by stimulating antitumor immune response in murine tumor.
    Masuda Y; Nakayama Y; Tanaka A; Naito K; Konishi M
    PLoS One; 2017; 12(3):e0173621. PubMed ID: 28278221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma.
    Sevko A; Sade-Feldman M; Kanterman J; Michels T; Falk CS; Umansky L; Ramacher M; Kato M; Schadendorf D; Baniyash M; Umansky V
    J Invest Dermatol; 2013 Jun; 133(6):1610-9. PubMed ID: 23223128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.
    Hanks BA; Holtzhausen A; Evans KS; Jamieson R; Gimpel P; Campbell OM; Hector-Greene M; Sun L; Tewari A; George A; Starr M; Nixon AB; Augustine C; Beasley G; Tyler DS; Osada T; Morse MA; Ling L; Lyerly HK; Blobe GC
    J Clin Invest; 2013 Sep; 123(9):3925-40. PubMed ID: 23925295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulatory effect of peritumorally administered interferon-beta on melanoma through tumor-associated macrophages.
    Kakizaki A; Fujimura T; Furudate S; Kambayashi Y; Yamauchi T; Yagita H; Aiba S
    Oncoimmunology; 2015 Nov; 4(11):e1047584. PubMed ID: 26451326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion.
    Zhang LJ; Chen L; Lu Y; Wu JM; Xu B; Sun ZG; Zheng SZ; Wang AY
    Eur J Pharmacol; 2010 Sep; 643(2-3):195-201. PubMed ID: 20621088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8
    Liu C; Chikina M; Deshpande R; Menk AV; Wang T; Tabib T; Brunazzi EA; Vignali KM; Sun M; Stolz DB; Lafyatis RA; Chen W; Delgoffe GM; Workman CJ; Wendell SG; Vignali DAA
    Immunity; 2019 Aug; 51(2):381-397.e6. PubMed ID: 31350177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice.
    Liu J; Zhang N; Li Q; Zhang W; Ke F; Leng Q; Wang H; Chen J; Wang H
    PLoS One; 2011 Apr; 6(4):e19495. PubMed ID: 21559338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo.
    Farsam V; Hassan ZM; Zavaran-Hosseini A; Noori S; Mahdavi M; Ranjbar M
    Int Immunopharmacol; 2011 Nov; 11(11):1802-8. PubMed ID: 21824530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
    Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
    Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance.
    Ravishankar B; Shinde R; Liu H; Chaudhary K; Bradley J; Lemos HP; Chandler P; Tanaka M; Munn DH; Mellor AL; McGaha TL
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4215-20. PubMed ID: 24591636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas.
    Fujimura T; Ring S; Umansky V; Mahnke K; Enk AH
    J Invest Dermatol; 2012 Apr; 132(4):1239-46. PubMed ID: 22189788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor macrophages as a target for Capsaicin mediated immunotherapy.
    Ghosh AK; Basu S
    Cancer Lett; 2012 Nov; 324(1):91-7. PubMed ID: 22579786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function.
    Dogan RN; Long N; Forde E; Dennis K; Kohm AP; Miller SD; Karpus WJ
    J Leukoc Biol; 2011 Jan; 89(1):93-104. PubMed ID: 20940325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Infusion of ex vivo expanded homologous CD4⁺;CD25⁺; regulatory T cells promotes the susceptibility to tumor in mice].
    Guo T; Luo S; Xu J; Dai J; Liu Z; Gao X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):466-70. PubMed ID: 24796739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma.
    Cho JH; Lee HJ; Ko HJ; Yoon BI; Choe J; Kim KC; Hahn TW; Han JA; Choi SS; Jung YM; Lee KH; Lee YS; Jung YJ
    Oncotarget; 2017 Apr; 8(15):24932-24948. PubMed ID: 28212561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sonodynamic therapy improves anti‑tumor immune effect by increasing the infiltration of CD8+ T cells and altering tumor blood vessels in murine B16F10 melanoma xenograft.
    Peng Y; Jia L; Wang S; Cao W; Zheng J
    Oncol Rep; 2018 Oct; 40(4):2163-2170. PubMed ID: 30106435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fucoidan inhibits CCL22 production through NF-κB pathway in M2 macrophages: a potential therapeutic strategy for cancer.
    Sun J; Sun J; Song B; Zhang L; Shao Q; Liu Y; Yuan D; Zhang Y; Qu X
    Sci Rep; 2016 Oct; 6():35855. PubMed ID: 27775051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.